PRO.MED.CS Praha a.s - Czech Republic   Report issue

For profit Phase 2
Founded: Prague Czech Republic (1989)
Status: No NME R&D (1989)

Organization Overview

First Clinical Trial
2016
NCT02941822
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

PRO.MED.CS Praha a.s.

Active Ingredients

Drugs in Phase 2 Trials (2)

ambroxol (1 trial)

ursodeoxycholic acid (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Parkinson Disease (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 2
  • # of Trial APIs: 2